Survey on Lymphedema After Sentinel Lymph Node Biopsy in People With Cervical or Vulvar Cancer

Launched by MEMORIAL SLOAN KETTERING CANCER CENTER · Feb 16, 2022

Keywords

ClinConnect Summary

This clinical trial is studying how some people might be at risk for developing a condition called lower extremity lymphedema (LEL) after a specific type of surgery called sentinel lymph node biopsy (SLN) for early-stage cervical or vulvar cancer. The goal is to gather information through a questionnaire from individuals who have undergone this surgery to help improve the guidance and support provided to patients. This research is important because understanding who may be at risk can lead to better care and information for patients going through similar treatments.

To participate in this study, you need to be a woman between the ages of 65 and 74 who has been diagnosed with early-stage cervical cancer or early-stage squamous cell carcinoma of the vulva. You should have had your primary surgery at the institution between January 2006 and January 2022 and be capable of understanding English and providing informed consent. During the study, you won’t receive any treatment or new medical tests; instead, you will simply complete a questionnaire about your experience. Your participation could help improve the quality of care for future patients facing similar surgeries.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Presented to MSK with newly diagnosed early-stage cervical cancer of any histologic profile or early stage vulvar cancer of any histologic profile.
• • °Early stage: Stage 1-2
• • Underwent primary surgery at our institution between January 2006 and January 2022.
• • Alive at the time of study activation
• • English comprehension
• • Capable of providing informed consent
• Exclusion Criteria:
• • Had documented macroscopic evidence of metastatic disease at the time of initial diagnosis